Microrna-362 Induces Cell Proliferation And Apoptosis Resistance In Gastric Cancer By Activation Of Nf-Kappa B Signaling

Jin-Tang Xia,Lian-Zhou Chen,Wei-Hua Jian,Ke-Bing Wang,Yong-Zhen Yang,Wei-Ling He,Yu-Long He,De Chen,Wen Li
DOI: https://doi.org/10.1186/1479-5876-12-33
IF: 8.44
2014-01-01
Journal of Translational Medicine
Abstract:Background: According to cancer-related microRNA (miRNA) expression microarray research available in public databases, miR-362 expression is elevated in gastric cancer. However, the expression and biological role of miR-362 in gastric progression remain unclear.Methods: miR-362 expression levels in gastric cancer tissues and cell lines were determined using real-time PCR. The roles of miR-362, in promoting gastric cancer cell proliferation and apoptosis resistance, were assessed by different biological assays, such as colony assay, flow cytometry and TUNEL assay. The effect of miR-362 on NF-kappa B activation was investigated using the luciferase reporter assay, fluorescent immunostaining.Results: MiR-362 overexpression induced cell proliferation, colony formation, and resistance to cisplatin-induced apoptosis in BGC 823 and SGC 7901 gastric cancer cells. MiR-362 increased NF-kappa B activity and relative mRNA expression of NF-kappa B-regulated genes, and induced nuclear translocation of p65. Expression of the tumor suppressor CYLD was inhibited by miR-362 in gastric cancer cells; miR-362 levels were inversely correlated with CYLD expression in gastric cancer tissue. MiR-362 downregulated CYLD expression by binding its 3' untranslated region. NF-kappa B activation was mechanistically associated with siRNA-mediated downregulation of CYLD. MiR-362 inhibitor reversed all the effects of miR-362.Conclusion: The results suggest that miR-362 plays an important role in repressing the tumor suppressor CYLD and present a novel mechanism of miRNA-mediated NF-kappa B activation in gastric cancer.
What problem does this paper attempt to address?